TNXP 8-K 2026-10-02

Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K dated 2026-10-02 — accession 0001493152-26-045603. This URL is the filing, not the TNXP hub.

Tonix Pharmaceuticals Holding Corp. (TNXP) is a biotechnology company listed on NASDAQ.

Tonix Pharmaceuticals Holding Corp. filed a 8-K on 2026-10-02. Accession 0001493152-26-045603.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TNXP revenue for 2025-12-31 was $13.1M. Net income was -$124.0M. Revenue was up 29.8% from 2024-12-31 to 2025-12-31. TNXP currently screens at market cap $194.5M.

Not investment advice. The TNXP SEC hub lists recent forms. The stock page is the research view.